These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 23134341)

  • 1. DNA-binding regulates site-specific ubiquitination of IRF-1.
    Landré V; Pion E; Narayan V; Xirodimas DP; Ball KL
    Biochem J; 2013 Feb; 449(3):707-17. PubMed ID: 23134341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the IRF-1 enhancer domain in signalling polyubiquitination and degradation.
    Pion E; Narayan V; Eckert M; Ball KL
    Cell Signal; 2009 Oct; 21(10):1479-87. PubMed ID: 19450680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Docking-dependent ubiquitination of the interferon regulatory factor-1 tumor suppressor protein by the ubiquitin ligase CHIP.
    Narayan V; Pion E; Landré V; Müller P; Ball KL
    J Biol Chem; 2011 Jan; 286(1):607-19. PubMed ID: 20947504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of Mdm2 acid domain interactions in recognition and ubiquitination of the transcription factor IRF-2.
    Pettersson S; Kelleher M; Pion E; Wallace M; Ball KL
    Biochem J; 2009 Mar; 418(3):575-85. PubMed ID: 19032150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Destabilizing missense mutations in the tumour suppressor protein p53 enhance its ubiquitination in vitro and in vivo.
    Shimizu H; Saliba D; Wallace M; Finlan L; Langridge-Smith PR; Hupp TR
    Biochem J; 2006 Jul; 397(2):355-67. PubMed ID: 16579792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dual-site regulation of MDM2 E3-ubiquitin ligase activity.
    Wallace M; Worrall E; Pettersson S; Hupp TR; Ball KL
    Mol Cell; 2006 Jul; 23(2):251-63. PubMed ID: 16857591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A site-directed mutagenesis study of the MdmX RING domain.
    Egorova O; Mis M; Sheng Y
    Biochem Biophys Res Commun; 2014 May; 447(4):696-701. PubMed ID: 24755078
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protein-Protein Interactions Modulate the Docking-Dependent E3-Ubiquitin Ligase Activity of Carboxy-Terminus of Hsc70-Interacting Protein (CHIP).
    Narayan V; Landré V; Ning J; Hernychova L; Muller P; Verma C; Walkinshaw MD; Blackburn EA; Ball KL
    Mol Cell Proteomics; 2015 Nov; 14(11):2973-87. PubMed ID: 26330542
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multiprotein binding interface in an intrinsically disordered region of the tumor suppressor protein interferon regulatory factor-1.
    Narayan V; Halada P; Hernychová L; Chong YP; Žáková J; Hupp TR; Vojtesek B; Ball KL
    J Biol Chem; 2011 Apr; 286(16):14291-303. PubMed ID: 21245151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulation of transcriptional activators by DNA-binding domain ubiquitination.
    Landré V; Revi B; Mir MG; Verma C; Hupp TR; Gilbert N; Ball KL
    Cell Death Differ; 2017 May; 24(5):903-916. PubMed ID: 28362432
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TRIAD1 inhibits MDM2-mediated p53 ubiquitination and degradation.
    Bae S; Jung JH; Kim K; An IS; Kim SY; Lee JH; Park IC; Jin YW; Lee SJ; An S
    FEBS Lett; 2012 Sep; 586(19):3057-63. PubMed ID: 22819825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A second p53 binding site in the central domain of Mdm2 is essential for p53 ubiquitination.
    Ma J; Martin JD; Zhang H; Auger KR; Ho TF; Kirkpatrick RB; Grooms MH; Johanson KO; Tummino PJ; Copeland RA; Lai Z
    Biochemistry; 2006 Aug; 45(30):9238-45. PubMed ID: 16866370
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-1 Tat Recruits HDM2 E3 Ligase To Target IRF-1 for Ubiquitination and Proteasomal Degradation.
    Remoli AL; Marsili G; Perrotti E; Acchioni C; Sgarbanti M; Borsetti A; Hiscott J; Battistini A
    mBio; 2016 Oct; 7(5):. PubMed ID: 27795392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mouse Double Minute 2 Homolog-Mediated Ubiquitination Facilitates Forkhead Box P3 Stability and Positively Modulates Human Regulatory T Cell Function.
    Wang A; Yang M; Liang R; Zhu F; Zhu F; Liu X; Han Y; Lin R; Wang X; Li D; Li H; Yuan X; Zhao H; Li B
    Front Immunol; 2020; 11():1087. PubMed ID: 32636834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIM-dependent enhancement of substrate-specific SUMOylation by a ubiquitin ligase in vitro.
    Parker JL; Ulrich HD
    Biochem J; 2014 Feb; 457(3):435-40. PubMed ID: 24224485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structure of IRF-3 bound to the PRDIII-I regulatory element of the human interferon-beta enhancer.
    Escalante CR; Nistal-Villán E; Shen L; García-Sastre A; Aggarwal AK
    Mol Cell; 2007 Jun; 26(5):703-16. PubMed ID: 17560375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular interaction between Smurf1 WW2 domain and PPXY motifs of Smad1, Smad5, and Smad6--modeling and analysis.
    Sangadala S; Metpally RP; Reddy BV
    J Biomol Struct Dyn; 2007 Aug; 25(1):11-23. PubMed ID: 17676934
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cbl and Itch binding sites in ERBB4 CYT-1 and CYT-2 mediate K48- and K63-polyubiquitination, respectively.
    Meijer IM; van Rotterdam W; van Zoelen EJ; van Leeuwen JE
    Cell Signal; 2013 Feb; 25(2):470-8. PubMed ID: 23153581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of c-Cbl as a new ligase for insulin-like growth factor-I receptor with distinct roles from Mdm2 in receptor ubiquitination and endocytosis.
    Sehat B; Andersson S; Girnita L; Larsson O
    Cancer Res; 2008 Jul; 68(14):5669-77. PubMed ID: 18632619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitination of p53 at multiple sites in the DNA-binding domain.
    Chan WM; Mak MC; Fung TK; Lau A; Siu WY; Poon RY
    Mol Cancer Res; 2006 Jan; 4(1):15-25. PubMed ID: 16446403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.